Latest News

Rapid-acting antidepressant for treatment-resistant depression: New insights

Researchers have generated fresh insights that could aid in the development of rapid-acting antidepressants for treatment-resistant depression. The researchers found that by blocking NMDA receptors with the drug ketamine, they could elicit rapid antidepressant effects in patients with treatment-resistant depression. Ketamine was developed as an anesthetic, but is better known publicly for its abuse as the party drug Special K. Researchers are now seeking alternatives because ketamine can produce side effects that include hallucinations and the potential for abuse -- limiting its utility as an antidepressant.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • New gadget helps vision-impaired to read graphs

  • Problem drinking in midlife doubles chance of memory problems in later life

  • Teen insomnia linked with depression, anxiety

  • Brain response to appetizing food cues varies among obese people

  • Parenting skills improve in ADHD parents with medication

  • Numerical learning disability: Dyscalculia linked to difficulties in reading and spelling

  • Sugar mimics guide stem cells toward neural fate

  • Laughter is the best medicine? The emotional appeal of stand-up comedy

  • Many depressed preschoolers still suffer in later school years

  • Naltrexone may be effective in diminishing impulse control disorders in Parkinson's disease patients

  •